Why You Can't Sleep on Peptides
Your body runs on blood sugar the way a car runs on fuel, and when the tank drops too low at two in the morning, your body doesn't just let you sleep through it.
It panics.
The panic response is a hormone cascade, specifically cortisol and adrenaline, that your brain triggers when glucose falls below a threshold it considers safe. Those hormones do their job, they pull stored glucose into circulation and bring blood sugar back up, but the side effect is that you wake up. Heart pounding, mind racing, wide awake at three in the morning for no obvious reason. People blame stress, they blame aging, they blame their mattress. What they're usually experiencing is a blood sugar rescue event.
This matters for peptide users because certain peptides, depending on what you're taking, create exactly the conditions that trigger this cascade while you're sleeping.
To understand why, you need a quick map of how blood sugar stays stable overnight under normal conditions.
When you eat during the day, glucose enters your blood and your pancreas releases insulin to move that glucose into cells for energy or storage. Some of that glucose gets stored in your liver as something called glycogen, which is essentially a short-term fuel reserve your body can break down and release back into the blood when levels drop. Overnight, your body draws on that reserve slowly, keeping blood sugar stable while you fast through sleep. If the reserve runs out, or if something causes a sharper-than-expected drop, the cortisol and adrenaline response kicks in.
Now there are two separate mechanisms through which peptides can disrupt this system, and they work in completely different ways.
The first applies to incretins, compounds like semaglutide, tirzepatide, and retatrutide. These drugs work by mimicking gut hormones that signal to your brain that you're full, which suppresses appetite significantly. In the Phase 2 trial on retatrutide, participants at the 12mg dose lost an average of 24.2% of their body weight over 48 weeks, which reflects just how powerfully these compounds drive caloric restriction. The problem is that appetite suppression doesn't come with a built-in floor. Your brain stops telling you to eat, so you eat less, sometimes dramatically less, and many people do this without realizing how little fuel they're actually putting in. Less food during the day means less glycogen stored going into the night. Less glycogen means your overnight fuel reserve is shallow. A shallow reserve runs out faster, blood sugar drops further, and the cortisol alarm goes off.
The second mechanism is different and applies to growth hormone secretagogues, compounds like CJC-1295, ipamorelin, and tesamorelin. These peptides stimulate your pituitary gland to release pulses of growth hormone, and most protocols call for dosing at night before bed because that's when the body's own natural GH release is highest. The issue is that growth hormone is fundamentally anti-insulin in its action.
The mechanism runs like this. Growth hormone increases the release of free fatty acids from fat tissue, and when those fatty acids flood into circulation, muscle cells preferentially burn fat for fuel instead of glucose. That shift means glucose isn't being taken up from the blood as efficiently, so blood glucose rises, insulin has to work harder to manage it, and the system becomes less sensitive overall. Research on this found that nocturnal GH pulses can increase hepatic glucose production by approximately 30%, which is the same mechanism behind what diabetologists call the dawn phenomenon, a morning blood sugar spike driven by the overnight GH surge. When you add an exogenous GH pulse on top of that natural rhythm, you're amplifying an already existing swing, and the glucose instability that follows is what triggers the cortisol response.
If you're running both an incretin and a secretagogue at the same time, both mechanisms are operating simultaneously. The incretin has left your glycogen reserve low coming into the night, and the GH pulse is creating additional glucose volatility on top of that. The conditions for a three in the morning cortisol spike become much more likely.
The practical solutions map directly onto the mechanisms.
If you're on an incretin and your appetite suppression is significant, the fix is deliberate eating. You have to override the appetite signal and eat enough during the day to build adequate glycogen stores before sleep. This is not about carbohydrates specifically. If you eat low carb or ketogenic, your body adapts through something called gluconeogenesis, which is a process where your liver manufactures glucose from protein and fat rather than from dietary carbs, and this can maintain adequate overnight blood sugar if total calorie intake is sufficient. The problem is not the macronutrient composition of your diet. The problem is when a drug removes your appetite signal and total food intake collapses.
If you're on a GH secretagogue, shifting your injection timing by a couple of hours earlier in the evening gives your blood sugar more time to stabilize before your deepest sleep. A small snack before bed containing protein and fat, not primarily sugar, can also act as a slow-releasing buffer that keeps blood sugar from dropping as far. The goal is not to spike glucose before bed but to give the liver something to work with through the night.
The deeper insight here is about how the body interprets chemical signals versus actual metabolic reality.
A peptide that makes you feel like you ate enough does not change whether your cells have enough fuel. And a peptide that triggers growth hormone release does not know that you're trying to sleep through it. These compounds are pharmacological levers that move physiology, and physiology responds to those levers the same way it responds to anything else, with the systems it already has. Cortisol at three in the morning is not a side effect of the peptide. It is your body doing exactly what it was designed to do when fuel runs low. The peptide just created the conditions for it.
Understanding that is the difference between troubleshooting your sleep and troubleshooting your system.
References
- Perriello G, De Feo P, Torlone E, et al. Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in Type 1 diabetes mellitus by decreasing hepatic and extrahepatic sensitivity to insulin in the absence of insulin waning. Diabetologia. 1990;331:52-59. Finding: Suppressing nocturnal GH spikes with somatostatin abolished the dawn phenomenon; restoring GH spikes reproduced it. Hepatic glucose production increased approximately 30%. Source
- Moller N, Jorgensen JO. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocrine Reviews. 2009;302:152-177. Finding: GH antagonizes insulin's hepatic and peripheral effects via increased free fatty acid flux and uptake. Source
- Jastreboff AM, Kaplan LM, Frias JP, et al. Triple-Hormone-Receptor Agonist Retatrutide for Obesity: A Phase 2 Trial. New England Journal of Medicine. 2023;3896:514-526. Finding: 24.2% mean weight loss at 12mg dose; significant appetite suppression documented across all dose groups. Source
Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness
If this is the kind of information you want access to on a daily basis, the community is free and there are full courses on training, nutrition, hormones, and supplementation inside. You can ask questions and post your own labs and get feedback from me and from the community.